DLH Holdings Corp., a provider of health care research, services and solutions to the federal government, has chosen Sandra Halverson as chief scientist.
Halverson will set company research and scientific priorities alongside the DLH executive leadership team. Additionally, she will serve as a public representative of the company with the goal of sharing DLH’s role in the public health and life sciences market.
The appointment will help expand DLH’s position in the public health and life sciences market area, said DLH President and CEO Zach Parker.
“In this time of public health crisis, our solutions in epidemiology, clinical trials, biomedical & environmental research including longitudinal studies, health policy analytics, and program evaluation are more vital than ever,” he added.
Halverson previously was director of DLH’s Survey Operations Center, as well as project director for the National Institute of Environmental Health Sciences Sister Study, a DLH-supported landmark research effort concerned with discovering causes of breast cancer. She joined DLH in 2012 from her tenure-tracked position as assistant professor of medicine at Vanderbilt University.
“We are thrilled that Sandra is taking on this larger role within DLH,” said Jeanine Christian, president of DLH’s Public Health and Scientific Research operating unit. “Her combination of discipline-specific knowledge, leadership skills, and business know-how will strengthen the competitive position of our company and ensure DLH is at the forefront of the latest scientific and technological advances.”
Halverson has a Ph.D. in epidemiology from the University of North Carolina, Chapel Hill, and a master’s degree in epidemiology and biostatistics from The George Washington University School of Public Health and Health Services.
